NovelStem International

NovelStem International is a company that specializes in the development and commercialization of diagnostic technology aimed at improving patient outcomes in various medical fields. The company focuses on applications in developmental biology, reproductive medicine, advanced cancer research, regenerative medicine, and genetic disease modeling. One of its key innovations is the ability to predict patients' resistance to anti-cancer drugs, enabling more targeted cancer treatments and potentially reducing the prevalence of chemotherapy resistance. Through its diagnostic solutions, NovelStem International aims to contribute to advancements in biomedical research and personalized medicine.